Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs)
pos +1.39
Today's Range: 50.76 - 52.11 | BMY Avg Daily Volume: 5,758,200
Last Update: 10/21/14 - 4:02 PM EDT
Volume: 6,676,499
YTD Performance: -4.87%
Open: $51.01
Previous Close: $50.56
52 Week Range: $46.30 - $57.49
Oustanding Shares: 1,657,904,666
Market Cap: 83,591,553,260
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 8 8
Moderate Buy 1 1 1 1
Hold 7 8 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.03 2.14 2.09 2.09
Latest Dividend: 0.36
Latest Dividend Yield: 2.88%
Dividend Ex-Date: 07/01/14
Price Earnings Ratio: 31.02
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
31.02 31.30 27.19
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.93% 1.69% 55.86%
Revenue -7.00 -0.16 -0.06
Net Income 3.20 -0.43 -0.17
EPS 32.90 -0.13 -0.05
Earnings for BMY:
Revenue 16.39B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.42 $0.41 $1.76 $1.72
Number of Analysts 9 8 13 13
High Estimate $0.48 $0.45 $1.82 $1.96
Low Estimate $0.36 $0.35 $1.70 $1.42
Prior Year $0.46 $0.51 $1.82 $1.76
Growth Rate (Year over Year) -9.66% -19.61% -3.04% -2.62%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Oct 16, 2014 | 8:13 AM EDT
BMY was upgraded to Outperform from Market Perform, BMO Capital said. $55 price target. Consensus expectations are low and have increas...
Stop picking on PepsiCo, Allergan and Apple.
Oct 08, 2014 | 8:16 AM EDT
BMY sell rating reiterated, said MKM. The company announced it will not seek FDA approval for two major drugs, and has withdrawn an add...
In the end, the market will find its feet. 

Finding a Place to Hide Real Money Pro($)

My strategy for when markets get choppy.
Aug 27, 2014 | 7:15 AM EDT
BMY was initiated with a Hold rating, Deutsche Bank said. Valuation call, based on a $52 price target. 
Not every futures-led decline is a terrific buying opportunity.
We have seen a huge correction, and we now need to look for signs that it is ending.
Weak competitors are now serving as prime takeover targets.
A wave of M&A in the health sector makes sense.

Columnist Conversations

Impressive and very broad based rally as tone has changed in market since middle of last week. Airlines conti...
Conclusion TWTR is growing revenue faster than any other peer. TWTR has worse net income margins than any othe...
THE FIBOCALL SPX-cash: Sometimes the choices are easy and sometimes they are quite hard. The upper end of the...
I had recommended packaged food manufacturer ConAgra (CAG) back on Feb. 12, 2014, when the shares were trading...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.